Bavarian Cancer Clinic Prescribed Medication to a Deceased PatientāNow Faces Legal Fallout
A cancer clinic in Bavaria prescribed medication for a deceased patient, leading to a legal dispute. The Munich Social Court ruled the prescription invalid after the health insurer demanded reimbursement. The case has highlighted gaps in communication between doctors and insurers when patients die.
The incident involved a prescription for Pamorelin, an injectable drug used in prostate cancer treatment. The patient had already passed away when the medication was issued. Upon discovering the error, the health insurer launched an investigation and sought repayment of ā¬489.52 from the clinic.
The court acknowledged the financial risks faced by oncologists but stressed that better practice management could prevent such mistakes. A simple phone call to confirm the patient's status might have avoided the unnecessary prescription. While the ruling did not impose penalties, it underscored the need for improved systems. The court also suggested that electronic patient records (ePA) could help by alerting doctors promptly when a patient dies. Despite Germany's ePA rollout in 2021, adoption has been slow, with fewer than 2% of insured individuals using it voluntarily by early 2025. The system became mandatory in January 2025, though patients can still opt out.
The ruling places responsibility on clinics to verify patient status before prescribing medication. It also points to broader systemic issues in how doctors receive updates about patient deaths. With ePA adoption still low, the case may push for faster integration of digital records in healthcare.
